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Measles IgG seroprevalence prior to mass vaccination in 
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Objectives: Measles vaccine was licensed for use inTaiwan in 1968 and mass vaccination has been implemented since 
1978. Serological surveys were conducted to characterize measles seroepidemiology prior to mass vaccination. 
Methods: Measles IgG was quantitatively measured in 1564 serum samples collected from four populations 
(nationwide, urban, rural, and mountain areas) during 1974-80 with a commercial EIA kit. The nationwide samples 
covered age groups from 3 months to 19 years, but the other three samples only covered school-aged children. The 
cut-off value of seropositivity was set at 100 mIU/ml. 
Results: In the nationwide samples, measles IgG seroprevalence decreased from 50% at 3-5 months to 13% at 6-11 
months, then increased rapidly to 55% at l-l.9 years and reached 98% at 7-7.9 years of age; this was maintained 
to young adulthood. In all four samples, seroprevalence also reached >97% in individuals >lO years of age. 
Semiquantitative analysis found that 24%(10/42) of 1-1.9-year-old children but only 4%(1/24) of 15-19-year-old 
adolescents had low level measles IgG (loo-399 mIU/ml). In addition, the distribution of measles IgG level in 1-1.9- 
year-old children had two peaks at 200-399 and 1600-3199 mIU/ml, whereas only one peak at 1600-3199 mIU/ml 
had been found in 15-19-year-old adolescents. The median age of measles infection (i.e. 50% seroprevalence) in 
Taiwan was 1.4 and 2.1 years, respectively, before and after excluding individuals with measles IgG loo-399 mIU/ml 
that may have resulted from vaccination. 
Conclusions: Measles seroepidemiology in Taiwan in the 1970s seemed to be more similar to that in a developing 
country rather than in an industrialized country, and there was a low median age of infection. 
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When mortality data are used, measles infection in 
Taiwan can be seen to be widespread, with nationwide 
epidemics occurring every two years before the intro- 
duction of mass vaccination in 1978 (Figure l).’ Since 
then, measles mortality has decreased significantly and 
only one fatal case was reported in 1983. However, the 
virus persisted in Taiwan and nationwide outbreaks 
continued to occur periodically in 198441985 and 1988- 
1989.2-3 Live attenuated measles vaccine was licensed 
for use in Taiwan in 1968. Mass vaccination programs 
with one dose of vaccine for children aged 15-21 months 
were instituted in 1978. The recommended ages for 
vaccination have been changed several times since 1978: 
a) two doses at 9 and 15 months of age in 1984; b) one 
dose at 12 months of age in January 1988; and c) two 
doses at 9 and 15 months of age in May 1988 because of 
the eruption of measles outbreaks.2-3 After the 1988- 
1989 outbreak, a national goal of measles elimination in 
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Taiwan by 2000 was established. Under this national 
goal, measles, mumps, and rubella (MMR) vaccine has 
been introduced since 1991 to replace the second dose 
of measles vaccine in 15-month-old children. In addition, 
a mass campaign with one dose of MMR vaccination 
among all primary and secondary schoolchildren was 
conducted during 1991-1994 and immunization require- 
ments have been implemented since 1994 by the check- 
ing of vaccination records and immunizing of unvaccin- 
ated individuals in children first attending kindergarten 
and primary school.4 
Seroepidemiology is a powerful tool for character- 
izing epidemiology of infectious disease and formulating 
control policy. Measles seroepidemiology prior to 
mass vaccination has never been investigated in Taiwan. 
In this study, serological surveys were conducted to 
estimate age-specific cumulative proportions of measles 
infection, which can be further used to formulate measles 
elimination policy in Taiwan. 
METHODS 
Study populations 
Populations with different demography may present 
different measles epidemiological characteristics.5-7 
Therefore, four populations representing nationwide, 
urban (Taipei City), rural (Houlung, Miaoli County) and 
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Table 1. Age-specific measles IgG seroprevalence among four study populations born prior to mass vaccination in Taiwan 
Age 
Months 
3-5 
6-11 
Years 
l-l.9 
2-2.9 
3-3.9 
4-4.9 
5-5.9 
6-6.9 
7-7.9 
8-8.9 
9-9.9 
10-14 
15-19 
Tota I 
Nationwide’ Urban Rural Mountain 
(1974-1977) (Taipei, 7979) (Miaoli, 1980) (1980) 
N /gG% (95% C/jt IgG%# N /gG% (95% C/J N /gG% (95% k/) N /gG% (95% C/J 
8 50(17-83) 50 Nosera Nosera No sera 
8 13 (1-53) 13 No sera Nosera Nosera 
42 55(39-70) 41 Nosera No sera Nosera 
34 62 (44-77) 55 No sera No sera No sera 
52 79(65-88) 76 No sera Nosera No sera 
30 77 (57-89) 76 No sera Nosera Nosera 
42 86(71-94) 85 Nosera No sera No sera 
57 88(76-95) 86 No sera Nosera No sera 
44 98(86-100) 98 Nosera 60 72(59-83) 60 97 (88-100) 
46 98(87-100) 98 22 100 (85-l 00) 55 87(76-95) 48 98 (89-l 00) 
43 93 (80-98) 92 25 100(86-100) 53 100(93-100) 54 100(93-100) 
104 97 (91-99) 97 166 99 (96-l 00) 171 99 (96-l 00) 164 97 (93-99) 
24 100(83-100) 100 142 100 (97-100) No sera No sera 
534 355 349 326 
‘Japanese encephalitis reported cases. 
+lgG%=measles IgG seroprevalence (measles IgG ~100 mlU/ml). The 95% confidence intervals (95% Cl) were calculated by Epi-Info 6.0 with the Fleiss 
quadratic method. 
*Seroprevalence after the exclusion of 49 individuals (21 year old) with measles IgG loo-399 mlU/ml. 
mountain (Taian, Miaoli County) areas were included. 
The population densities in these four areas in 1979 
were 486 (nationwide), 8070 (urban), 622 (rural), and 11 
(mountain) persons/km2, respectively.8 Five hundred 
and thirty four sera collected from nationwide Japanese 
encephalitis reported cases in 1974-1977, 355 sera 
collected from the urban residents in 1979 for a 
serosurvey of hepatitis A antibody, 349 sera collected 
from the rural schoolchildren in 1980 and 326 sera 
collected from the mountain schoolchildren in 1980 for 
a serosurvey of Japanese encephalitis antibody, were 
available. Although measles infection can cause 
encephalitis, suspected cases of Japanese encephalitis do 
nqt have rash as a symptom and can be differentiated 
clinically from measles. Therefore, the nationwide 
samples are unlikely to overestimate measles sero- 
prevalence. All sera had been kept at -20°C in the 
National Institute of Preventive Medicine, Taipei, 
Taiwan. The age distribution of the study samples is 
shown in Table 1. 
Serological test 
Measles IgG was quantitatively measured with a serum 
dilution of 1:41 by a commercial ELISA kit (Human 
GmbH, Wiesbaden, Germany) and adjusted into 
mIU/ml with WHO standard serum.9 The WHO 
standard serum was diluted to 100,200, 500,1000, and 
5000 mIU/ml in duplicate to obtain a standard curve for 
each plate. The test was valid only for the condition 
where the standard curve had a high correlation 
coefficient (R2>0.95) between measles IgG titers and 
optical density (OD). Sera with OD less than the mean 
OD of the 100 mIU/ml standard serum were classified 
as seronegative. The measles IgG titers of sera with OD 
greater than the mean OD of the 100 mIU/ml standard 
serum were calculated from the standard curve. One 
positive and one negative control serum were included 
in each plate. 
Data analysis 
Age-specific measles IgG seroprevalence was calculated 
based on the cut-off value of 100 mIU/ml. In addition, 
for the nationwide samples, measles IgG titer was semi- 
quantitatively categorized into 100-399, 400-999 and 
~1000 mIU/ml, and additionally, expressed as the geo- 
metric mean titer (GMT) in each age group (sero- 
negative individuals excluded). The 95% confidence 
intervals (95% CI) of age-specific measles IgG 
seroprevalence and GMT were calculated with Epi-Info 
6.0.1° Before mass vaccination in 1978, measles vaccine 
was licensed for use from 1968. Vaccine coverage was 
estimated to be considerably lower than 10% because of 
the charge for vaccination. l1 To examine the confound- 
ing of measles vaccination, two age groups with high 
(l-l.9 years) and low (15-19 years) possibility of 
vaccination were selected to analyze the distribution of 
measles IgG levels. In an unvaccinated population, the 
age with 50% seroprevalence (AGO) approximates to 
median age at infection, which is a useful indicator to 
represent the infectivity of infectious agents in a com- 
munity. Aso was calculated with the Reed-Muench 
formula by assuming the linear relationship between age 
and seroprevalence in two age groups that span 50% 
seroprevalence.12 
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Figure 1. The annual number of reported measles cases and measles mortality rates in Taiwan. Measles vaccine (MV) was 
introduced in 1968 and mass immunization started in 1978. Measles became a reportable disease in 1985 and laboratory 
confirmation started in 1992. The number of confirmed cases from 1992 to 2000 were 7, 2, 34, 0, 0, 7, 9, 0 and 5, respectively. 
Mortality rates were calculated from the number of persons aged <19-yearsas a denominator, because only three fatal cases 
occurred among persons aged >I9 years. No death attributable to measles has been identified since 1991. 
RESULTS 
Measles IgG seroprevalence 
Measles IgG seroprevalence in the nationwide samples 
decreased from 50% at 3-5 months to 13% at 6-11 
months, then increased rapidly to 55% at l-l.9 years, 
62% at 2-2.9 years, 79% at 3-3.9 years, and reached 98% 
at 7-7.9 years, which was approximately maintained to 
young adulthood (Table 1). Seroprevalence in 7-year-old 
children in the nationwide (98%, 95% CI: 86-100%) and 
mountain (97%, 95% CI: 88-100%) samples was higher 
than that in the rural samples (72%, 95% CI: 59-83%) 
(P=O.O004 and 0.0001, respectively, with the use of the 
two-tailed Fisher’s exact test) (Table 1). In all four 
samples, seroprevalence approached 100% in individuals 
210 years old (Table 1). 
Figure 2 shows that measles IgG GMT in the 
nationwide samples increased from 188 mIU/ml in 
children <l year old to 653 mIU/ml in those aged ,l-1.9 
years old and was maintained at 1033-1995 mIU/ml in 
2-19-year-old individuals. Semiquantitative analysis 
found 24% (10/42) of 1-1.9-year-old children but only 
4% (l/24) of 15-19-year-old adolescents had measles 
IgG loo-399 mIU/ml (P=O.O46; two-tailed Fisher’s exact 
test), which may result from measles vaccination (Figure 
2). Figure 3 shows that only five sera had measles IgG 
titers between 300 and 400 mIU/ml, and the seropositive 
titers seem to scatter in two ranges (> 400 and 100-300 
mIU/ml). Figure 4 further demonstrated that the distri- 
bution of measles IgG titer in 1-1.9-year-old children 
had two peaks at 200-399 mIU/ml and 1600-3199 
mIU/ml, whereas only one peak at 1600-3199 mIU/ml 
was found in 15-19-year-old adolescents. Therefore, to 
reduce the potential confounding effect of measles 
vaccination, 49 (9.2%) individuals who were aged 21 
year and had measles IgG loo-399 mIU/ml were 
excluded for the estimation of ASO. After the adjustment, 
Aso increased from 1.4 to 2.1 years, but the sero- 
prevalence in age groups aged ~3 years did not change 
significantly (Table 1). 
DISCUSSION 
Representative samples are critical to seroepidemio- 
logic studies. A nationwide sample based on random 
sampling is most suitable but this kind of sample 
collected before 1978 was not available in Taiwan. 
Alternatively, serum samples collected in public health 
Table 2. Age-specific seroprevalence of measles IgG (m-IgG) among different populations in Taiwan 
Age 
(years) 
Nation wide Rural2 
1974-77 1988 
N m-IgG N m-IgG 
Urbanz5 
1993 
N m-IgG 
Urbanz6 
1993-95 
N m-IgG 
Mountainz7 
1995-96 
N m-IgG 
RuralZ7 
1997 
N m-IgG 
Urbanz7 
1997 
N m-IgG 
l-3 128 (66%) 295 (80%) 229 (88%) 93 (95%) 115 (97%) 140 (95%) 
4-6 129 (84%) 203 (93%) 159 (91%) 175 (87%) 152 (96%) 143 (95%) 
7-l 0 133 (96%) 772 (88%)* 203 (93%) 117 (92%) 257 (93%) 171 (97%) 174 (99%) 
11-15 104 (97%) 386 (93%)* 140 (94%) 166 (95%) 251 (99%) 207 (99%) 273 (99%) 
16-20 24 (100%) 51 (90%) 109 (94%) 158 (99%) 100 (99%) 
>20 42 (88%) 214 (90%) 10 (100%) 44 (100%) 31 (100%) 
Cut-off (mlU/ml) 100 240t 240t 240t 50 50 50 
*The IgG seroprevalences before an outbreak were estimated based on measles IgG and IgM tests during an outbreak. 
tThe standardized cut-off of seropositivity was not defined in the original studies and was based on the study of Hesketh et al.28 
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Figure 2. The age-specific distribution and geometric mean titer (GMT) of measles IgG titers in the nationwide serum samples 
collected in 1974-1977 in Taiwan. The standard deviation (SD) of GMT is also shown. 
laboratories or hospitals for other purposes not related 
to the disease under study can be used to monitor the 
population immunity profiles.13-l5 In this study, sera 
collected entirely from nationwide Japanese encephalitis 
(JE)-reported cases were used because of their avail- 
ability and distinguishable clinical symptoms from 
measles. The nationwide Japanese encephalitis sera 
were more likely to represent those areas where JE was 
more common. However, the nationwide JE sera can be 
used to study nationwide seroprevalence of measles 
0 2 4 6 8 10 12 14 16 18 20 
Age (years) 
Figure 3. Scatter plot of measles IgG titers by age. 
Seronegative sera were recorded as 50 mlU/ml. 
45 
IgG, since JE (transmitted by mosquitoes) and measles 
do not have a similar geographical pattern. In addition, 
practically it is not feasible to obtain serum samples 
collected totally from unvaccinated young children, 
since the measles vaccine was introduced to Taiwan 
since 1968. Therefore, adjustments to exclude the 
confounding of vaccination were necessary. It is well 
documented that measles infection induces higher 
antibody titers than does vaccination.16-I8 In this study, 
the distribution of measles IgG titers in a young age 
group (l-l.9 years) had two peaks at 200-399 and 
1600-3199 mIU/ml, but adolescents born before 
vaccination was available had only a single peak at 
1600-3199 mIU/ml. So it can be inferred that those 
young children with low titers may have received 
measles vaccination and also had not been infected. 
Therefore, the authors used the quantitative measles 
IgG titer as a criterion to exclude the potential 
confounding of vaccination. After the adjustment, Aso 
prior to mass vaccination in Taiwan was 2.1 years, which 
was similar to other developing countries in the 1950- 
1970s but younger than that in developed countries (4-7 
years).5-7,1g 
When measles antibody seroprevalence is used to 
estimate the cumulative proportions of measles infec- 
tion prior to mass vaccination, it is better to use sera 
collected for several years including epidemic and non- 
epidemic periods. 5,1g Before 1978, nationwide measles 
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epidemics occurred every two years in Taiwan. Sera 
collected between 1974 and 1977 were used that would 
include epidemic and non-epidemic periods (Figure 1). 
Although they are not as appropriate as seroprevalence 
data, clinical data can also be used to estimate the cumu- 
lative proportions of measles infection prior to mass 
vaccination, since measles asymptomatic infection in 
unvaccinated individuals is rare and natural infection 
induces life-long immunity.5 Among 334 measles cases 
diagnosed in a pediatric clinic in central Taiwan in 
1976-1977,20 the age-specific cumulative proportions 
were 17.1% at 1 year of age, 70.4% at 4 years of age and 
99.1% at 8 years of age, which is consistent with the 
measles IgG seroprevalence (i.e. 13, 76, and 98%, 
respectively) in this study (Table 1). 
Aso is a useful indicator to represent infectivity of 
infectious agents in a community.21 ASI is sometimes 
preferred to the mean age at infection as an indicator 
of infectivity because it can be interpolated directly 
from seroprevalence profiles, whereas the latter requires 
more tedious calculation (i.e., adjusting for the compo- 
sition of age distribution) and is not an appropriate 
index when the age at infection does not distribute 
normally. 21 Taiwan and other developing countries has 
lower AX, than developed countries prior to mass 
vaccination, which implies measles is more infectious 
and more difficult to control in developing than in 
developed countries. 5-7~19 In addition, measles seems to 
have lower Aso than rubella, mumps, poliomyelitis, and 
smallpox, which also implies measles virus was more 
difficult to eradicate globally.5,22 
The factors related to lower Aso in developing 
countries may include high population density and birth 
rate. Population density is strongly related to the 
dynamics of measles infection, such that communities 
with higher population density (urban areas or large 
households) have higher measles infection rates and 
lower Aso relative to communities with a lower popu- 
lation density.5-7J9 In this study, the authors found that 
measles IgG seroprevalence in the 7-year-old group in 
the rural samples was significantly lower than that in the 
nationwide and mountain samples. The mountain area 
had a lower population density than the rural area but 
had a higher seroprevalence in the 7-year-old group 
60% 
cl00 lOO+ 200+ 400+ 800+ 1600+ 3200+ 6400+ 
IgG Titre (Log scale) 
Figure 4. The distribution of measles IgG titers in two age 
groups in Taiwan, 1974-1977. 
than that in the rural area. This may be related to larger 
household sizes in mountain areas than those in rural 
areas in the 1970~.~~ Furthermore, developing countries 
always have a higher birth rate than do developed 
countries.When more susceptible persons are introduced 
to a community, measles outbreaks are more likely to 
occur.5-7Jg Prior to mass vaccination, measles epidemics 
occur with a shorter cycle in areas with a high popu- 
lation density and high birth rate than in areas with a 
low population density and low birth rate (l-2 years vs 
3-5 years). - 5 7~19 Overall, it may need higher vaccine 
coverage to prevent measles outbreaks in communities 
with a high population density, such as nurseries and 
schools. In addition, the optimal age for measles 
vaccination will be lower in areas with low AXI than in 
areas with high Aso. 
The optimal age for measles vaccination needs to be 
justified with the possibility of natural infection and 
vaccine failure. In 1978, measles vaccination policy in 
Taiwan was one dose at 15-21 months of age. This policy 
was changed to two doses at 9 and 1.5 months of age in 
1984, since infants represented a high-risk group for 
measles and measles-associated deaths.le3 The two-dose 
policy during 1984-1987 was not implemented very 
well, with intermediate coverage rates (73-89%) for the 
first dose and low coverage rates (~70%) for the second 
dose.24 Therefore, nationwide measles epidemics 
occurred repeatedly during 1984-1985 and 1988-1989.2-3 
A serological study estimated that population immunity 
in a primary school was 88% before the 1988-1989 
epidemic (Table 2).2 After the mass campaign of MMR 
vaccination in 1991-1994 and the implementation of 
immune requirements in kindergarten and primary 
school since 1994, no confirmed case was detected in 
1995-1996, five sporadic confirmed cases occurred in 
1997, and a small outbreak with nine confirmed cases 
erupted in 1998.8 Serological data showed that the 
population immunity in Taiwan has reached >95% in 
the school population (7-20 years) but ~95% in the 
preschool children (l-6 years) in the late 1990s (Table 
2).25-28 Since measles activity is so low that infants have 
a low probability of exposure to measles cases, it has 
been proposed to change the recommended age of the 
first dose from 9 months to 12 months for reducing 
vaccine failures and inducing higher antibody titers.4,27 
As shown in this study, measles was highly infectious 
prior to mass vaccination in the 1970s in Taiwan. The 
annual birth rate in Taiwan has decreased from 25 per 
1000 in the 1970s to 16 per 1000 in the 1990s but 
population density has increased from 450 to 590 
persons/km2, respectively.* Therefore, when the measles 
virus is imported internationally, it could be as highly 
transmissible as in the 1970s. To ensure that infants do 
not become a high risk group as a result of changing the 
recommended age at first dose from 9 to 12 months, 
vaccine coverage in preschool and schoolchildren will 
need to be maintained at high levels. Epidemiological 
models based on empirical data in Taiwan suggest that 
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the current measles vaccination policy may be changed 
to two doses of MMR vaccine at 1 and 6 years of age for 
reducing vaccine failures and inducing higher antibody 
titers if the coverage rate of the first dose at 1 year of age 
can be reached over 90%.29 Since secondary vaccine 
failures are not rare in rubella vaccinees,3O the best 
policy for two doses of MMR needs to consider the 
overall impact on measles, mumps, and rubella control. 
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